Skip to main content

Halozyme Therapeutics, Inc.

HALO
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001159036

In the last 90 days, Halozyme Therapeutics, Inc. insiders filed 0 open-market purchases and 5 sales; 674 institutions reported holding it in 13F filings for Q2 2026, worth $9.62B in total; no superinvestor holds it.

13F holders, Q3 2024

Institutional positions in Halozyme Therapeutics, Inc. as of Sep 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
510
+54 vs. Q2 2024
Shares held
125.3M
+20.7M (+19.8%) vs. Q2 2024
Total value
$7.17B
+$1.69B (+30.8%) vs. Q2 2024
New holders
95
180 more added
Sold out
41
167 more reduced

4 institutions that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q2 2024: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting HALO on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ3 2024: 510 institutions
Q1 2021: 337 institutionsQ2 2021: 315 institutionsQ3 2021: 326 institutionsQ4 2021: 326 institutionsQ1 2022: 316 institutionsQ2 2022: 368 institutionsQ3 2022: 357 institutionsQ4 2022: 423 institutionsQ1 2023: 387 institutionsQ2 2023: 370 institutionsQ3 2023: 390 institutionsQ4 2023: 411 institutionsQ1 2024: 413 institutionsQ2 2024: 460 institutionsQ3 2024: 510 institutionsQ4 2024: 509 institutionsQ1 2025: 550 institutionsQ2 2025: 552 institutionsQ3 2025: 604 institutionsQ4 2025: 619 institutionsQ1 2026: 637 institutionsQ2 2026: 674 institutions
Value heldQ3 2024: $7.17B
Q1 2021: $5.53BQ2 2021: $5.89BQ3 2021: $5.29BQ4 2021: $5.21BQ1 2022: $5.12BQ2 2022: $5.65BQ3 2022: $5.21BQ4 2022: $7.35BQ1 2023: $4.77BQ2 2023: $4.45BQ3 2023: $4.71BQ4 2023: $4.62BQ1 2024: $5.03BQ2 2024: $6.40BQ3 2024: $7.17BQ4 2024: $5.86BQ1 2025: $7.72BQ2 2025: $6.05BQ3 2025: $8.75BQ4 2025: $8.29BQ1 2026: $7.79BQ2 2026: $9.62B
Institutions holding HALO and their total value by quarter
QuarterHoldersValue
Q2 2026674$9.62B
Q1 2026637$7.79B
Q4 2025619$8.29B
Q3 2025604$8.75B
Q2 2025552$6.05B
Q1 2025550$7.72B
Q4 2024509$5.86B
Q3 2024510$7.17B
Q2 2024460$6.40B
Q1 2024413$5.03B
Q4 2023411$4.62B
Q3 2023390$4.71B
Q2 2023370$4.45B
Q1 2023387$4.77B
Q4 2022423$7.35B
Q3 2022357$5.21B
Q2 2022368$5.65B
Q1 2022316$5.12B
Q4 2021326$5.21B
Q3 2021326$5.29B
Q2 2021315$5.89B
Q1 2021337$5.53B

Institutions, Q3 2024

Shares, value and share of portfolio for each institution holding Halozyme Therapeutics, Inc.; share changes are against Q2 2024.

Institutions holding HALO in Q3 2024
InstitutionSharesValue% of portfolioChange in sharesAction
Congress Asset Management Co2,433,579$139.3M0.95%+1,988,238+446.5%Added
JPMorgan Chase & Co2,864,857$164.0M0.01%−206,997−6.7%Reduced
Macquarie Group Ltd3,010,825$172.3M0.19%−66,702−2.2%Reduced
Geode Capital Management, LLC3,060,131$175.2M0.01%+30,901+1.0%Added
Artisan Partners Limited Partnership3,133,412$179.4M0.27%−583,852−15.7%Reduced
Alliancebernstein L.P.3,408,341$195.1M0.07%−140,734−4.0%Reduced
Snyder Capital Management L P4,063,367$232.6M4.83%+23,455+0.6%Added
State Street Corp6,633,688$379.7M0.02%+819,481+14.1%Added
Vanguard Group Inc12,895,096$738.1M0.01%+13,637+0.1%Added
BlackRock, Inc.17,430,019$997.7M0.02%+17,430,019New
Citadel Advisors LLC0$00.00%−347,699−100.0%Sold out
Bernzott Capital Advisors0$00.00%−187,249−100.0%Sold out
Amundi0$00.00%−120,427−100.0%Sold out
Trexquant Investment LP0$00.00%−100,076−100.0%Sold out
Advisors Preferred, LLC0$00.00%−97,310−100.0%Sold out
Voloridge Investment Management, LLC0$00.00%−80,110−100.0%Sold out
Balyasny Asset Management LLC0$00.00%−58,897−100.0%Sold out
Readystate Asset Management LP0$00.00%−57,970−100.0%Sold out
Connor, Clark & Lunn Investment Management Ltd.0$00.00%−37,082−100.0%Sold out
Bayesian Capital Management, LP0$00.00%−31,260−100.0%Sold out
Ontario Teachers Pension Plan Board0$00.00%−30,405−100.0%Sold out
Entropy Technologies, LP0$00.00%−24,969−100.0%Sold out
Brevan Howard Capital Management LP0$00.00%−19,808−100.0%Sold out
Aquatic Capital Management LLC0$00.00%−16,900−100.0%Sold out
Algert Global LLC0$00.00%−12,791−100.0%Sold out
Oak Hill Wealth Advisors, LLC0$00.00%−10,800−100.0%Sold out
HRT Financial LP0$00.00%−9,155−100.0%Sold out
Centiva Capital, LP0$00.00%−8,884−100.0%Sold out
Unique Wealth Strategies, LLC0$00.00%−10,943−100.0%Sold out
Argent Trust Co0$00.00%−7,592−100.0%Sold out
Omers Administration Corp0$00.00%−6,200−100.0%Sold out
Vinva Investment Management Ltd0$00.00%−4,066−100.0%Sold out
Fox Run Management, L.L.C.0$00.00%−5,001−100.0%Sold out
Laurion Capital Management LP0$00.00%−4,791−100.0%Sold out
O'Neil Global Advisors, Inc.0$00.00%−4,750−100.0%Sold out
nVerses Capital, LLC0$00.00%−4,700−100.0%Sold out
Capstone Investment Advisors, LLC0$00.00%−4,230−100.0%Sold out
Mercer Global Advisors Inc0$00.00%−3,484−100.0%Sold out
United Capital Financial Advisers, LLC0$00.00%−3,858−100.0%Sold out
Sectoral Asset Management Inc0$00.00%−3,815−100.0%Sold out
Catalyst Funds Management Pty Ltd0$00.00%−3,600−100.0%Sold out
Central Pacific Bank - Trust Division0$00.00%−3,070−100.0%Sold out
IFP Advisors, Inc0$00.00%−2,027−100.0%Sold out
Front Row Advisors LLC0$00.00%−139−100.0%Sold out
Triad Wealth Partners, LLC0$00.00%−85−100.0%Sold out
Stephens Consulting, LLC0$00.00%−68−100.0%Sold out
Innealta Capital, LLC0$00.00%−68−100.0%Sold out
Continuum Advisory, LLC0$00.00%−28−100.0%Sold out
JNBA Financial Advisors0$00.00%−24−100.0%Sold out
Valley National Advisers Inc0$00.00%−30−100.0%Sold out
Harbor Investment Advisory, LLC0$00.00%−4−100.0%Sold out
BlackRock Inc.––––Not filed
Susquehanna Fundamental Investments, LLC––––Not filed
Hoylecohen, LLC––––Not filed
Benjamin F. Edwards & Company, Inc.––––Not filed